# Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

> **NCT01552902** · PHASE4 · COMPLETED · sponsor: **Shire** · enrollment: 549 (actual)

## Conditions studied

- Attention-deficit/Hyperactivity Disorder

## Interventions

- **DRUG:** Lisdexamfetamine dimesylate
- **DRUG:** Methylphenidate Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01552902
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-03
- **Primary completion:** 2014-05-22
- **Final completion:** 2014-05-22
- **Target enrollment:** 549 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01552902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01552902, "Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01552902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*